RetroSense Therapeutics Company
RetroSense Therapeutics is a biotechnology company developing gene therapy for vision restoration.
Investors
Headquarters:
Ann Arbor, Michigan, United States
Technology:
Neurological Disorders
Industry:
Gene Therapy
Total Funding:
$106M
Estimated Revenue:
Less than $1M
Investors Number:
12
Founded Date:
2009
Last Funding Type:
Venture - Series Unknown
Funding Status:
M&A

%20.jpg)
.png)












